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Summary Introduction
Beckwith-Wiedemann syndrome (BWS) is a disorder ofBeckwith-Wiedemann syndrome (BWS) is an autosomal
prenatal overgrowth characterized by abdominal walldominant disorder of increased prenatal growth and
defects, macroglossia, ear creases and pits, hemihyper-predisposition to embryonal cancers such as Wilms tu-
trophy, enlargement of the kidney and liver, and neona-mor. BWS is thought to involve one or more imprinted
tal hypoglycemia. BWS patients also show a 1,000-fold-genes, since some patients show paternal uniparental
increased risk of embryonal tumors, including Wilmsdisomy, and others show balanced germ-line chromo-
tumor, rhabdomyosarcoma, and hepatoblastoma (Wie-somal rearrangements involving the maternal chromo-
demann 1983). We and others previously had mappedsome. We previously mapped BWS, by genetic linkage
BWS to 11p15.5 by genetic-linkage analysis (Koufos etanalysis, to 11p15.5, which we and others also found
al. 1989; Ping et al. 1989), in which some patients hadto contain several imprinted genes; these include the
shown balanced germ-line chromosomal rearrange-gene for insulin-like growth factor II (IGF2) and H19,
ments (Waziri et al. 1983; Turleau et al. 1984; Okanowhich show abnormal imprint-speciﬁc expression and/
et al. 1986). These rearrangements speciﬁcally involveor methylation in 20% of BWS patients, and p57KIP2, a
the maternal chromosome, and other BWS patientscyclin-dependent kinase inhibitor, which we found
show paternal uniparental disomy (UPD) (Henry et al.showed biallelic expression in one of nine BWS patients
1991), suggesting that the BWS gene is imprinted—thatstudied. In addition, p57KIP2 was recently reported to
is, is expressed from a speciﬁc parental allele. To date,show mutations in two of nine BWS patients. We have
we and others have identiﬁed four imprinted genes onnow analyzed the entire coding sequence and intron-
11p15.5: (1) IGF2 is a paternally expressed autocrineexon boundaries of p57KIP2 in 40 unrelated BWS pa-
growth factor (Giannoukakis et al. 1993; Ogawa et al.tients. Of these patients, only two (5%) showed muta-
1993; Ohlsson et al. 1993; Rainier et al. 1993); (2) H19tions, both involving frameshifts in the second exon. In
is a maternally expressed, untranslated RNA (Moultonone case, the mutation was transmitted to the proband’s
et al. 1994; Steenman et al. 1994) that may serve as amother, who was also affected, from the maternal
tumor-suppressor gene (Hao et al. 1993); (3) p57KIP2 isgrandfather, suggesting that p57KIP2 is not imprinted in
a cyclin-dependent kinase inhibitor proposed, on theat least some affected tissues at a critical stage of devel-
basis of its map location (Matsuoka et al. 1995), as aopment and that haploinsufﬁciency due to mutation of
BWS or tumor-suppressor gene, which we found to beeither parental allele may cause at least some features
expressed from the maternal allele (Matsuoka 1996);of BWS. The low frequency of p57KIP2 mutations, as
and (4) KvLQT1 encodes a potassium channel expressedwell as our recent discovery of disruption of the KvLQT1
preferentially from the maternal allele (Lee et al. 1997).gene in patients with chromosomal rearrangements, sug-
Of these genes, all have shown alterations in BWS.gest that BWS can involve disruption of multiple inde-
First, we and others described abnormal imprint-speciﬁcpendent 11p15.5 genes.
expression and/or methylation affecting IGF2 and H19
in the embryonal tumors to which BWS patients are
predisposed, as well as in normal tissues of BWS patients
(Ogawa et al. 1993; Rainier et al. 1993; Weksberg et
al. 1993; Steenman et al. 1994; Reik et al. 1995). WeReceived January 10, 1997; accepted for publication May 20, 1997.
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tients were recently found to harbor apparent mutations TGACC and reverse primer CCCCAGGTGCGCTGTA;
and H19, forward primer CAATGAGGTGTCCCA-in the coding sequence of p57KIP2, one of which was also
present in the proband’s mother (Hatada et al. 1996). GTTCCA and reverse primer CACATAAGTAGGCGT-
GACTTGA. PCR reactions contained 0.5 mM primers,This was thought to play a causal role, since imprinting
would lead to nonexpression of the gene, since the pater- 0.2 mM dNTP, 50 ng DNA, 1 1 PCR buffer A (In-
Vitrogen), 12.5% dimethyl sulfoxide, 1.6 mg BSA/ml,nal allele is normally silent (Hatada et al. 1996). Third,
we have recently found that ﬁve BWS chromosomal re- and 0.6 units Pfu DNA polymerase (Stratagene) in 25
ml and were performed with a Robocycler (Stratagene),arrangement breakpoints on 11p15 (the so-called
BWSCR1 cluster) are spanned by the KvLQT1 gene and as follows: initial denaturation at 95C for 3 min, fol-
lowed by 30 cycles each of 95C for 1 min, 60C for 1that this gene is also normally imprinted and expressed
from the maternal allele (Lee et al. 1997). min, and 74C for 1.5 min, and a ﬁnal primer extension
at 74C for another 7 min. PCR products were resolvedOur initial studies of a smaller number of BWS pa-
tients revealed no mutations in p57KIP2. The purpose of on 2% agarose gels, were puriﬁed by use of a Qiaex gel
extraction kit (Qiagen), and were either sequenced withthe experiments described here was to determine the
frequency of p57KIP2 mutations in a much larger number an ABI automatic sequencer or digested with the indi-
cated restriction enzymes. Sequence analysis was per-of patients than that examined by us or by Hatada et
al. (1996), as well as its pattern of transmission. formed by use of the Sequencher program (Gene Codes)
and visual inspection of the chromatogram. To conﬁrm
the presence of mutations, we subcloned PCR productsSubjects and Methods
in the PCR2.1 vector and sequenced several independent
BWS Patients clones from both normal and mutant alleles.
All patients in this study were part of a self-referred
BWS registry. A subset of patients was examined by one Results
of us if they reported at least two of the following fea-
p57KIP2 is a general inhibitor of G1 cyclin-dependenttures: macroglossia, birth weight and length above the
kinases, and it is closely related to p27KIP1 (Lee et al.90th percentile, hypoglycemia in the 1st mo of life, ear
1995; Matsuoka et al. 1995). p57KIP2 contains three do-creases or pits, and abdominal wall defects (omphalo-
mains—a Cdk-inhibitory domain shared amongcele, diastasis recti, and umbilical hernia). Only samples
p21CIP1, p27KIP1, and p57KIP2; a highly polymorphic hex-from patients both having a diagnosis of BWS conﬁrmed
anucleotide repeat encoding proline-alanine (PAPA re-by physical examination by board-certiﬁed geneticists
peat): and a domain containing glutamine and threonineand for whom other syndromes were excluded were sub-
(QT domain), conserved between p27KIP1 and p57KIP2.jected to molecular analysis.
The exon-intron genomic structure, along with the pro-
tein domains, are illustrated in ﬁgure 1. We designed sixIsolation of DNA
sets of PCR primers (ﬁg. 1), in order to amplify theCells were suspended in TE9 (0.5 M Tris.HCl, pH
entire coding region and exon-intron boundaries. These9.0, 20 mM EDTA, 10 mM NaCl), digested with pro-
six sets of PCR primers ensured that there was enoughteinase K (0.2 mg/ml) in the presence of 1% SDS at 50C
overnight, puriﬁed by phenol/chloroform extraction,
and precipitated with sodium acetate/ethanol.
PCR Ampliﬁcation and Sequencing Analysis
The following primers were used: primer set 1, for-
ward primer GGGCCATGTCCGACGCGTCCCTCC-
GCA and reverse primer GCGGTTCTGGTCCTCGGC-
GTTCAGCTC; primer set 2, forward primer GGAGCT-
GAGCCGCGAGCTGCAGGCCCG and reverse primer
CAGCAGGCGGCAGCGCCCCACCTGCAC; primer
set 3, forward primer CTTCCAGCAGGACATGCC-
GCTG and reverse primer TGGAGCCAGGACCGG-
GACT; primer set 4, forward primer ACTGCCTAG-
TGTCCCGGTC and reverse primer GTCAGCGAG-
Figure 1 Structure of the human p57KIP2 gene. The exon-intronAGGCTCCTGG; primer set 5, forward primer GGC-
structure is based on the genomic sequence of p57KIP2 (Tokino et al.
GCCTCAAGAGAGCGCCGAGCAGGG and reverse 1996). Shaded boxes denote the predicted protein domains. Sets 1–6
primer GGGACCGGCCGGCCGGACAAAGCGGGG; indicate the PCR fragments used for sequencing. The sequences of the
primers are given in the Subjects and Methods.primer set 6, forward primer CGACGTAAACAAAGC-
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overlapping sequence between adjacent PCR fragment, thus contains neither the Cdk-inhibitor domain nor the
QT domain and is a true null mutant.since sequencing toward the ends of PCR fragments is
less reliable. Genomic DNAs were isolated from either The mutation in patient 2 was also a frameshift muta-
tion, in this case in PCR fragment 4, initially detectedﬁbroblast or lymphoblastoid cells from 40 BWS patients
and were used to amplify the p57KIP2 gene. PCR frag- by direct sequencing of PCR products and then con-
ﬁrmed by subcloning and sequencing of multiple sub-ments were sequenced directly by use of an ABI auto-
matic sequencer. Because of the extensive overlap of clones (ﬁg. 2, right). This frameshift mutation, like that
in patient 1, was also caused by deletion of a singlethese PCR fragments, many regions of the p57KIP2 gene
were sequenced twice. If there was any ambiguity, we nucleotide, in this case a T at nucleotide 705. The muta-
tion, like that in patient 1, creates a truncated proteinalso sequenced the complementary strand.
In this manner, we analyzed each nucleotide of the lacking the PAPA and QT domains. Patient 2 also
showed typical features of BWS, including macroglossiaentire coding region and exon-intron boundaries of the
p57KIP2 gene, for the presence of mutations in 40 BWS requiring surgery, as well as ear pits, nevus ﬂammeus,
and omphalocele. We do not know whether other familypatients. Of these patients, only two patients showed
mutations in the p57KIP2 gene. Both were frameshift mu- members carry the mutation, since the patient was
adopted and her biological parents therefore are un-tations due to deletion of a single nucleotide. Patient 1
was the proband of a BWS family in our earlier genetic- available for study. We observed no additional muta-
tions in the remaining 38 BWS patients. Thus, germ-linelinkage study (family B in Ping et al. 1989). She had all
the common features of BWS, including hypoglycemia, mutations of p57KIP2 were found in only 5% of the large
number of BWS patients analyzed here.ear creases, macroglossia, craniofacial anomalies, and
omphalocele. She also developed neuroblastoma. Both We and others previously had shown that BWS in
some patients involves alterations of imprint-speciﬁcher mother and her maternal grandfather were also af-
fected, although to a lesser degree. They both had ear methylation of a CpG island in the H19 gene (Steenman
et al. 1994; Reik et al. 1995). In order to determinecreases and craniofacial anomalies. The mother also had
macroglossia, and the maternal grandfather had cryp- whether p57KIP2 mutations might exert an indirect effect
on the genomic imprinting of other 11p15 genes, wetorchidism. The sequencing chromatogram of patient 1
by use of primer set 1 revealed deletion of a single nucle- used a sensitive and speciﬁc PCR assay (Jinno et al.
1996) to examine allele-speciﬁc methylation of H19 inotide at position 347 (data not shown; the nucleotide
coordinates are given in ﬁg. 1). To conﬁrm the apparent a BWS patient with a p57KIP2 mutation. The primers
spanned both a polymorphic invariably unmethylatedmutation, we then subcloned the PCR fragment and
sequenced several individual subclones. The sequence HhaI site and a HpaII site that is normally methylated
only on the paternal chromosome. Patient 1 was hetero-analysis conﬁrmed deletion of a single nucleotide G347
(ﬁg. 2, left). As further conﬁrmation of the mutation, zygous for the a and b alleles, and her mother was homo-
zygous for the a allele (ﬁg. 4). Therefore, the a allele ofthe deletion of G347 in patient 1 also generates a pre-
dicted EagI site, CGGCCG (ﬁg. 2, left). Segment 1 is patient 1 is of maternal origin, and the b allele is of
paternal origin. Digestion with HpaII prior to PCR abol-185 bp, and digestion of the mutant allele with EagI
generates two fragments, 109 bp and 75 bp (ﬁg. 3a). ished the a allele only. Thus, the H19 gene is normally
methylated, at least at one imprint-speciﬁc site, on theIndeed, digestion of the PCR fragment from patient 1
showed three bands—185 bp, 109 bp, and 75 bp (ﬁg. paternal chromosome in patient 1, and the p57KIP2 muta-
tion in this patient did not disturb the imprint-speciﬁc3b, lane 1)—corresponding to the wild-type and mutant
alleles. The mutant allele was also present in the mother methylation of H19 at that site.
(ﬁg. 3b, lane 2) and maternal grandfather (ﬁg. 3b, lane
4) of patient 1, but it was not present in the maternal Discussion
grandmother, a maternal aunt, and two unrelated indi-
viduals (ﬁg. 3b, lanes 3 and 5–7). The mutation in the By direct sequencing in 40 BWS patients, we have
analyzed the entire coding region and intron-exonmother and the grandfather, as well as the absence of
mutation in the grandmother and the maternal aunt, boundaries of the p57KIP2 gene, in order to detect muta-
tions unequivocally. We have found only two, althoughwere also conﬁrmed by direct sequencing (data not
shown). The EagI site was also not present in 50 unre- both of these are likely to result in loss of function, since
they are both frameshift mutations disrupting most oflated individuals (data not shown). Therefore, the
frameshift mutation in patient 1 cosegregated with the the coding sequence of the gene.
There are three major implications of these data. First,disease, and it was not seen in any unaffected individu-
als. The frameshift mutation would create a truncated mutations of p57KIP2 account for a small fraction of
BWS—only 5% of the large number of patients studiedprotein retaining the ﬁrst 24 amino acids and followed
by six new amino acids (ﬁg. 2). The truncated protein here, which is even less than the frequency (22%) in
/ 9a30$$au22 08-01-97 12:13:14 ajhga UC-AJHG
307Lee et al.: p57KIP2 Mutation in Beckwith-Wiedemann Syndrome
Figure 2 p57KIP2 mutations in BWS patients. Left, Patient 1. The PCR fragment from primer set 1 was subcloned in PCR2.1. Four subclones
from both normal and mutant alleles were sequenced, giving identical results. The mutant allele showed deletion of a single nucleotide G, as indicated.
Note the generation of an EagI site, CGGCCG (underlined in the ﬁgure) in the mutant allele, and the frameshift creating a truncated protein with
24 N-terminal amino acids plus 6 new amino acids. Right, Patient 2. The PCR fragment from primer set 4 was subcloned. Two subclones from
both normal and mutant alleles were sequenced. A single nucleotide-T deletion was detected in the mutant allele, as indicated.
the smaller series (nine patients) reported recently by seems unlikely, since similar mutations were not seen,
by us or others, in non-BWS patients. In one of ourHatada et al. (1996). What could account for this low
frequency? One possibility is that the mutations are rare patients (patient 1) and in one of the Japanese patients,
the mother also carried the mutation, suggesting a func-null polymorphisms unrelated to BWS. This possibility
tional defect, since the maternal allele of p57KIP2 is nor-
mally expressed. The family of patient 1 studied here
also shows cosegregation of the mutation with the dis-
ease over three generations. A second possibility is that
most BWS arises by virtue of imprinting errors leading
to silencing of p57KIP2. We earlier described biallelic ex-
pression of p57KIP2 in a patient with BWS, which could
be due either to increased expression of the paternal
Figure 3 Cosegregation of the mutant allele with disease, in the
family of patient 1. a, Restriction-digestion map of PCR fragment 1. The
predicted size of the normal allele is 185 bp. The mutant allele acquires
an EagI site (see underlined sequence CGGCCG in ﬁg. 2, left). Digestion
of the PCR fragment with EagI generates 109-bp and 75-bp fragments. Figure 4 Paternal origin–speciﬁc methylation of H19 unaf-
fected in patient 1. The diagram indicates the expected ampliﬁcationb, EagI digestion of PCR fragments frompatient 1, other familymembers,
and unrelated individuals. Lane 1, Patient 1. Lane 2, Mother. Lane 3, products of two alleles, with use of primer set H19 forward and
reverse primers. The a allele gives a 435-bp fragment, wheres the bMaternal grandmother. Lane 4, Maternal grandfather. Lane 5, Maternal
aunt. Lanes 5 and 6, Two unrelated individuals. The sizes of the three allele gives two fragments, of 190 bp and 245 bp, because of the
presence of a HhaI site. Minus signs (0) and plus signs (/) indicate,DNA fragments are indicated on the right side. Note that patient 1, her
mother, and the maternal grandfather are all affected, and they are all respectively, absence and presence of HpaII digestion before PCR am-
pliﬁcation; ‘‘M’’ denotes DNA from the mother of patient 1.heterozygous for the mutation.
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allele or to relative silencing of the maternal allele to a both IGF2 and p57KIP2. Consistent with this hypothesis,
it has recently been found that at least one chromo-level comparable to that of the paternal allele (Thomp-
son et al. 1996). However, the frequency of this alter- somal-rearrangement patient shows loss of imprinting of
IGF2 (Brown et al. 1996). The low frequency of p57KIP2ation also appears to be low. A third possibility is that
BWS involves epigenetic silencing of p57KIP2 by an im- mutations reported here, as well as our recent discovery
of disruption of the KvLQT1 gene in patients with chro-print-independent mechanism. We earlier observed re-
duced expression of p57KIP2 in the hyperplastic tongue mosomal rearrangements, suggest that BWS can involve
disruption of multiple 11p15.5 genes.of six BWS patients, but the gene was also found to be
transcriptionally inactive in the tongue of normal pa-
tients of comparable age (Thompson et al. 1996).We are
Acknowledgmentscurrently examining the expression of p57KIP2 in affected
prenatal tissues, to test this hypothesis. This work was supported by National Institutes of Health
The second major implication of these data is that grant CA54358 and March of Dimes grant 6-FY96-1048. We
mutations in p57KIP2 can be associated with BWS when thank J. Patey for preparing the manuscript.
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